Sun Pharma Settles Patent Suits Over Generic Ethyol

Law360, New York (August 3, 2009, 2:37 PM EDT) -- Sun Pharmaceutical Industries Ltd. and one of its subsidiaries said Monday that they had settled patent litigation with MedImmune LLC over their sale of a generic form of the cancer therapy drug Ethyol.

India-based Sun and U.S. affiliate Caraco Pharmaceutical Laboratories Ltd. have been granted a patent license that will enable them to continue marketing generic Ethyol in the U.S., the companies said in separate statements.

The settlement resolves litigation over Sun's abbreviated new drug application for the drug that has been pending in the U.S....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.